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In discussing the development of investigations of gastrointestinal function it should be pointed out that the investigations used have depended on the views of contemporary workers regarding the actual function of this tract. Investigative methods have thus advanced with increasing knowledge of gastrointestinal physiology. Initially it was believed that the stomach was the main organ of digestion and absorption, but Claude Bernard in the early nineteenth century demonstrated the importance of pancreatic secretions and of intestinal absorption. With time there has come increasing knowledge of the details of absorption and of the regulation of digestive processes, and more recently the concept has developed of the gastrointestinal tract as a first-line monitor of nutrients entering the body.
Initially the clinical problems which engaged most interest were peptic ulceration, malignant disease, and diarrhoea-particularly steatorrhoea. Some of these disorders have been with us for a long time. In fact one of my colleagues in Manchester recently felt able to deliver a lecture entitled '10000 Years of Diarrhoea'. More recently, however, the spectrum of gastrointestinal disease has been greatly widened and the need for function tests has become more demanding.
Tests ofgastric function
The work of Prout, Beaumont, and Schmidt demonstrated by 1852 that hydrochloric acid was produced in the stomach and that digestion of meat occurred there. Aspiration of gastric contents started when Kussmahl used it in 1869 to relieve the symptoms of pyloric stenosis. The credit for the first test meal goes to Leube, who, in 1883 gave a meal of steak and mashed potatoes, aspirating the gastric contents 7 h later. This was largely a study of gastric emptying and is of interest in view of recent developments. Ewald introduced his I-h test three years later, and 1890 saw the introduction by Boas of oatmeal gruel as a test meal. Thus developed the fractional test meal which became part of the standard investigation of gastric function for over half a century.
It was not until 1921 that Bennett and Ryle clarified the wide range of normal response by performing the test on 100 of their medical students. Histamine was introduced as a stimulus of gastric secretion in 1927, but gradually it became apparent that all available tests using submaximal stimulation were unsatisfactory. The basic problem was that they were unable by measuring a concentration of acid to differentiate between several processes going on in the stomach simultaneously. The tendency to hypersecretion in duodenal ulcer was established as was achlorhydria in pernicious anaemia, but the main benefit of the fractional test meal was to cast doubt on the diagnosis of duodenal ulcer if hypoacidity was found and to cast doubt on the diagnosis of pernicious anaemia if acid was present. The test was unreliable for positive diagnosis of these two conditions and is, in fact, no more discriminating for duodenal ulcer than examination of the basal secretions alone.
More recently attention has been devoted to an assessment of functional parietal cell mass by determination of the maximal acid output-that is, the rate of hydrochloric acid secretion after maximal stimulation. This requires not only the measurement of the concentration of hydrochloric acid but the quantitative recovery of gastric secretions in a defined time period in the absence of any foodstuffs given orally. The technique is therefore much more demanding. The stimulus was originally histamine in higher dose, later replaced by Histalog with reduction in undesirable side effects. More recently these stimulants have, in this country, largely been replaced by pentagastrin, now widely regarded as the stimulant of choice. When one looks at the benefits of this more elaborate investigation they are not so impressive as was hoped. There is still argument about the best way of expressing the results. The normal range is still wide and many cases of duodenal and gastric ulcer fall within it. The test is, however, reliable for establishing true achlorhydria as seen in pernicious anaemia and in a minority of cases of gastric carcinoma.
The test has been much used by surgeons in an attempt to decide on the most appropriate form of operation for the patient suffering from peptic ulcer. Unfortunately there is no good evidence that tailoring the operation to the result of the test has materially altered the postoperative result, particularly in so far as recurrent ulceration is concerned. Many surgeons are now performing simpler gastric operations, often a vagotomy with an additional pyloroplasty if this is indicated. It is therefore desirable to have a test to assess whether the vagal stimulation of gastric secretion has been effectively interrupted. The test most used has been to employ insulin to achieve hypoglycaernia which causes intense vagal stimulation. Again there has been argument about the best dose of insulin and the best way of expressing the results. In several published series the test demonstrates an apparent rather high failure rate to achieve vagal section even in the hands of experienced gastric surgeons. As it has now been shown that hypoglycaemia can also release gastrin and thus cause non-vagal gastric stimulation, the test is apparently less specific than once was hoped.
What other aspects of gastric function should be considered? Methods of measuring the rate of emptying of liquid from the stomach are now available using dye techniques and have demonstrated that in gastric ulcer delayed emptying may more than offset the tendency to hyposecretion of acid long demonstrated in this condition. But there is still little information on what happens with the more physiological solid meals despite the first work by Leube 90 years ago. Here is an area for future development. Also, despite the traditional use of antacids in treating peptic ulcers, there is still very little information on the pH achieved in the stomach throughout the whole 24-h period with different regimens. The investigation of this problem may require new methods of continuous monitoring of gastric pH but will surely be extended.
Tests of small intestinal function
Initial interest centred on steatorrhoea, but more recently investigation of the selective function of different zones of the small intestine has extended the range of investigations to cover other clinical problems.
By 1900, methods for the determination of fat and nitrogen in dried faeces were established, as was the microscopic examination of stools. The flat glucose tolerance curve in steatorrhoea was also known. The introduction in 1949 by Van de Kamer of a simple wet technique for faecal fat is still the mainstay of the detection of abnormalities arising from either defective digestion or defective absorption. The test was refined by extension into fat balance studies and improvements were suggested by the use of various faecal markers. None the less the investigation cannot be regarded as one of the more popular of clinical chemical methods. Efforts have been made for at least 25 years to replace it. Stanley and Thannhauser introduced the use of fats labelled with radio-iodine in 1949, and many modifications were suggested during the next 15 years but have been largely discredited. The uptake of isotope can be studied by serial serum determinations but these demonstrate the result not only of absorption but 157 also of simultaneous removal of the labelled fat. Similar criticisms apply to the study of the chylomicron response in serum to a fatty meal, to the vitamin A absorption test, and to the measurement of serum carotene. All these tests have a rather poor correlation with the faecal fat excretion and the same is unfortunately true of the faecal excretion of radioiodinated fats. It looks as if the faecal fat method is to be with us for some time yet, but here is scope for future development.
The investigation of the selective function of the small intestine has been more rewarding. The jejunum normally has a different function and structure from that of the ileum. Although loss of jejunal function in disease may be compensated for by an increase in the absorption by the ileum of materials normally handled higher up, loss of ileal function, particularly where disease damages the last metre, cannot be compensated for.
The jejunum is concerned with the absorption of the common end products of the digestion of food. The ability to absorb carbohydrate has been elegantly demonstrated using the xylose tolerance test, employing this rather poorly absorbed pentose which does not normally occur in bowel contents as a convenient model. Several variants of the test are described, but its usefulness is unchallenged. Folate absorption is also jejunal and absorption difficulties can lead to important clinical deficiencies. These may beassessed by determination of red cell folate or by a formiminoglutamic acid test after a loading dose of histidine. Disaccharides are now known to be split by specific enzymes in the brush border of the jejunal cell before absorption. The first case of congenital alactasia was described by Holzel in Manchester in 1959, and it has since been realised that acquired deficiencies particularly of lactase are not uncommon and are involved in some cases of recurrent diarrhoea. Investigations to demonstrate this defect include the lactose tolerance test and, more directly, the examination of jejunal biopsies obtained perorally with the Crosby capsule technique. Much more has been learned about the absorption of the products of protein digestion from the intestine. Thus we have seen the work demonstrating the presence of the same transport mechanisms for amino acids in the jejunum and in the renal tubule, thus clarifying some of the biochemical features of disordered intestinal function in certain aminoacidurias. We have also seen the delineation of mechanisms for the absorption of small peptides in addition to the amino acids themselves. This sheds light on intestinal function in certain disorders and can well lead to further differentiation of disease processes affecting the small intestine and to the improvement of malnutrition in cases where amino-acid absorption is impaired.
With respect to the ileum, recently we have obtained the fascinating knowledge that it is vital for the absorption of vitamin B12 and for bile salt metabolism. A variety of abnormalities of the terminal ileum may share the common feature of the development of a B12-deficiency megaloblastic anaemia without achlorhydria or intrinsic factor deficiency, once the three years' supply of vitamin B12, normally stored in the liver, is exhausted. The absorption of radioactive B12 has helped in the investigation of these cases. The position of bile salts in disease processes has attracted enormous attention during the last few years. It is now known that 80 % of bile salts are reabsorbed through the ileum and are re-excreted by the liver so that the total body pool of bile salts is turned over twice with each meal. These recirculating bile salts are important in maintaining cholesterol in solution in the bile and in the emulsification, digestion, and absorption of neutral fats in the intestine. The enterohepatic circulation in its role of effectively washing out cholesterol from the biliary system has indeed been likened to the role of circulating solvent in the Soxhlet extractor. Bile salts which escape reabsorption are deconjugated and dehydroxylated in the colon. The resultant bile acids are irritant to the colonic mucosa and if present in excess can lead to watery diarrhoea. One of the colonic products, lithocholic acid, has been shown to be preferentially reabsorbed from the colon, and on re-excretion by the liver its presence in the bile disturbs the delicate physicochemical harmony between cholesterol and the other bile salts, thereby assisting in gall-stone formation. Indeed, lithocholic acid was so named because it was first isolated from gall-stones. These developments in bile salt metabolism have led to a greater understanding of the reasons for the development of cholelithiasis, of steatorrhoea, and of watery diarrhoea in conditions such as Crohn's disease which damage the terminal ileum.
Our increasing knowledge of small intestinal physiology has led to the more careful description of small intestinal diseases. Thus the segregation of gluten-sensitive enteropathy can be taken as one example. The fundamental nature of the disease is still uncertain, but immunological evidence suggests that in some cases at least an ineffective release of IgA with reduced protection to the entry of toxic peptides is an important factor. The syndrome of protein-losing enteropathy has become established as an important cause of obscure hypoproteinaemias and a variety of tests of varying degrees of suitability and reliability have been devised to study the problem. Progress has also been made in our understanding of the 'blind-loop' or 'stagnant-loop' syndrome which can affect all parts of the intestine from duodenum to sigmoid colon. The demonstration of a considerable colonisation of such stagnant areas by colonic bacteria has led to the suggestion that bacterial deconjugation of bile salts is the cause of the diarrhoea and impaired fat absorption seen in such cases. Degradation of amino acids also occurs, and this has led to a revival of the determination of urinary indican, a product of the bacterial decomposition of trypophan. Whatever the biochemical niceties of the situation, the therapeutic response to appropriate antibiotics greatly benefits the patient, the ultimate aim of all laboratory investigations.
Pancreas and the gastrointestinal tract as an endocrine organ
Initial interest in the pancreas was in the control of its secretion and in such clinically obvious diseases as acute pancreatitis. In 1844, amylase was found in pancreatic juice and it had been demonstrated in blood and urine by 1867. The first method for amylase in the investigation of patients was described by Dr. Roberts, a physician at Manchester Royal Infirmary, who introduced an amyloclastic method in 188I. The first saccharogenic method followed five years later, but the more popular Wohlgemuth method did not appear until 1908. Claude Bernard demonstrated the presence of lipase in pancreatic juice in 1846 and olive oil substrates for its assay were tried in 1880. These apparently were not satisfactory judged by the later introduction of simpler substrates such as ethyl butyrate and tributyrin. By 1912 or so, workers were beginning to question whether the two types of substrate measured the same enzyme, an argument which still has a familiar sound. The earliest method for trypsin appears to be that of Sahli who in 1897 used entericcoated capsules containing iodoform, salicylate, or methylene blue and inferred tryptic activity from their appearance in the urine.
The history of the study of the control of pancreatic secretion is a long one. As long ago as 1828, Leuret and Lassaigne in France showed that the animal pancreas was stimulated to secrete if acetic acid was placed in the duodenum. They were quite clear also about the physiological implications for the entry of acid chyme from the stomach into the duodenum. Pavlov in 1888 confirmed this finding and showed that vagal stimulation was also capable of inducing secretion. He attributed a nervous basis to both methods of stimulation and it was left to Bayliss and Starling at University College, London in 1902 to demonstrate that the entry of acid into the upper intestine liberated a chemical substance from the mucosa. This substance they called 'secretin' and then introduced the word 'hormone' (Gk opj-taw I arouse to activity) in 1905 to describe this new class of substances. In 1905 also, Edkins postulated the release of another hormone, gastrin, from the gastric mucosa. Later work has fully vindicated the existence of both these hormones. They were both obtained in pure form in 1961 and their structures were determined in 1966.
Cholecystokinin, a hormone causing gall bladder contraction, was postulated by Ivy's group in the late 1920s. Claude Bernard however had demonstrated that bile flow increased in animals after acid was placed in the duodenum. It is now known that this stimulus causes the release of cholecystokinin and that this hormone is identical with pancreozymin, which was originally characterised by Harper and Raper working in Manchester in 1943. Purification of cholecystokinin-pancreozymin has demonstrated that this substance, whose structure was established as recently as 1971, does in fact possess both the activity of causing gall bladder contraction and the secretion of pancreatic juice rich in enzymes, a useful combination when one considers the need of pancreatic lipase to work in the presence of bile salts.
Recently we have seen the characterisation of other gastrointestinal hormones-gastric inhibitory polypeptide, vasoactive intestinal polypeptide, and enteroglucagon. Although radioimmunoassay of these hormones is still in its infancy, only gastrin being firmly established at present, this will surely be a growing point in the investigation of gastrointestinal function in disease in the future. Already it is clear that these several hormones are released in a logical order and work together to provide an integrated control of the secretory, digestive and, perhaps, absorptive functions of the stomach and small intestine.
Certainly the availability of secretin and pancreomyzin as specific pancreatic stimulants has allowed the development of pancreatic function tests, a subject dating back to the early observations of Chiray and colleagues in Paris who in 1926 first gave secretin to humans and collected the contents of the duodenum. Although much still remains to be done in the classification and study of pancreatic disease, much has also been achieved by these methods.
The increasing knowledge of the gastrointestinal hormones has been paralleled by the realisation that a system of cells widely distributed through the body but especially associated with the gastrointestinal tract are intimately concerned with the elaboration of such hormones. The concept has emerged therefore of a vast endocrine organ extending over the whole gastrointestinal tract, quite different from the localised collections of endocrine cells in such 159 organs as the pituitary, thyroid, or adrenal. This system of cells has been christened the APUD system as it is concerned either with amine content or Amine Precursor Uptake and Decarboxylation. Whenever the function of particular cells is defined it is tempting to look for the occurrence of tumours arising from such cells, tumours which may have endocrine activities. These tumours have now been classified as the apudomas and include such long established tumours as those causing the carcinoid syndrome. Other syndromes have been grouped under this heading and are of special interest to the gastroenterologist. The Zollinger-Ellison syndrome has been known since 1955 and is recognised as a gastrin-producing pancreatic adenoma in most cases. In 1958 a similar pancreatic tumour was described in association with severe watery diarrhoea, a conjunction aptly described as pancreatic cholera We are still uncertain as to the nature of the hormone secreted but the latest indication is that it is gastric inhibitory polypeptide, according to Elias and colleagues in 1972 . Similarly an interesting tumour apparently secreting enteroglucagon has also been reported.
In addition to this concept of an endocrine organ regulating its own activity, there has been increasing awareness that the gastrointestinal hormones also playa role in the regulation of internal metabolism by influencing such well established homeostatic agents as insulin and pancreatic glucagon. They appear to modify general metabolism, including substances other than glucose, in a way which matches the flow of different nutrients from the intestine. The gastrointestinal endocrine system is perhaps best regarded as a monitor of the external supply of nutrients, modulating internal metabolism appropriately. This is an exciting area of future development but it is salutory to realise that the first observations in this field were made by Biedl and Kraus in Vienna in 1896 and that Bayliss and Starling in 1902 were convinced that secretin had something to do with carbohydrate metabolism. They did in fact try the effect of crude secretin in treating diabetics with some apparent success. This was at a time 13 years after von Mering and Minkowski had demonstrated that the pancreas was involved with diabetes, but 20 years or so before the discovery of insulin.
At the time the Association of Clinical Biochemists was founded the work load of the laboratory was much less than at present and the view has often been expressed that life was much more leisurely in the laboratory then. How much more leisurely might it have been in 1902 with Bayliss and Starling? I wondered about this and was startled to find that they could certainly move quickly when necessary.
Only seven days after carrying out the first injection of crude secretin and demonstrating its physiological action, they reported the findings at a meeting of the Royal Society! This rapid communication of a discovery of fundamental importance must rarely have been equalled.
This review of the investigation of gastrointestinal function should indicate that not only has the topic a promising future but that it has an equally illustrious past and present. There is an obvious analogy to the development of the Association of Clinical Biochemists which must surely be mentioned on this occasion, its coming of age.
